Efficacies of ofloxacin, rifampin, and clindamycin in treatment of Staphylococcus aureus abscesses and correlation with results of an in vitro assay of intracellular bacterial killing

Antimicrob Agents Chemother. 1997 May;41(5):1178-81. doi: 10.1128/AAC.41.5.1178.

Abstract

We studied the efficacies of ofloxacin, rifampin, and clindamycin in a Staphylococcus aureus abscess model and seven antimicrobial regimens in an intracellular killing assay. Ofloxacin plus rifampin was the most effective regimen in the abscess model, and rifampin and ofloxacin were the most active regimens in the intracellular killing assay.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Abscess / drug therapy*
  • Animals
  • Anti-Infective Agents / blood
  • Anti-Infective Agents / therapeutic use*
  • Antibiotics, Antitubercular / blood
  • Antibiotics, Antitubercular / therapeutic use*
  • Clindamycin / blood
  • Clindamycin / therapeutic use*
  • Microbial Sensitivity Tests
  • Models, Biological
  • Ofloxacin / blood
  • Ofloxacin / therapeutic use*
  • Rabbits
  • Rats
  • Rifampin / blood
  • Rifampin / therapeutic use*
  • Staphylococcal Infections / drug therapy*
  • Staphylococcus aureus / drug effects

Substances

  • Anti-Infective Agents
  • Antibiotics, Antitubercular
  • Clindamycin
  • Ofloxacin
  • Rifampin